PI
BHVN

Putnam Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Putnam Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-101,368
Closed -$15.3M – 1237
2022
Q3 		$15.3M Sell
101,368
-8,095
-7% -$1.2M 0.03% 223
2022
Q2 		$15.9M Buy
109,463
+22,240
+25% +$2.84M 0.03% 229
2022
Q1 		$10.3M Buy
87,223
+1,541
+2% +$192K 0.02% 335
2021
Q4 		$11.8M Buy
85,682
+2,933
+4% +$373K 0.02% 334
2021
Q3 		$11.5M Sell
82,749
-21
-0% -$2.62K 0.02% 330
2021
Q2 		$8.04M Buy
82,770
+2,500
+3% +$203K 0.01% 418
2021
Q1 		$5.49M Hold
80,270
– – 0.01% 478
2020
Q4 		$6.88M Sell
80,270
-871
-1% -$73.8K 0.01% 439
2020
Q3 		$5.28M Sell
81,141
-90
-0.1% -$5.9K 0.01% 471
2020
Q2 		$5.94M Buy
81,231
+16,164
+25% +$860K 0.01% 434
2020
Q1 		$2.21M Sell
65,067
-370
-0.6% -$16.9K 0.01% 591
2019
Q4 		$3.56M Buy
+65,437
New +$3.24M 0.01% 596

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Putnam Investments's BHVN Position: Q4 2022 in Review

Putnam Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 101,368 shares — an estimated $15.3M sold.

Putnam Investments first reported a position in BHVN in Q4 2019 and held it in 12 quarters. The position peaked at $15.9M in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Putnam Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Putnam Investments sold 101,368 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $15.3M.
  • Putnam Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 12 quarters.
  • Putnam Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $15.9M in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.